9 3 5215 Pill - yellow capsule/oblong, 13mm
Pill with imprint 9 3 5215 is Yellow, Capsule/Oblong and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg. It is supplied by Teva Pharmaceuticals USA.
Hydrochlorothiazide/moexipril is used in the treatment of High Blood Pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 9 3 5215
Hydrochlorothiazide and Moexipril Hydrochloride
- Imprint
- 9 3 5215
- Strength
- 25 mg / 15 mg
- Color
- Yellow
- Size
- 13.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- ACE inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
povidone k30,
sodium bicarbonate,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide,
FD&C Red No. 40,
FD&C Yellow No. 5,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-5215 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0578 (Discontinued) | AvKare, Inc. |
| 54868-3443 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about hydrochlorothiazide / moexipril
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: ACE inhibitors with thiazides
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
